One Turn Open the globe →Globe →

The story so far · 2 days, November 16 to 17, 2026

Novo says Wegovy lowers BMI in children in trial

One Turn followed this story across 2 editions, from Copenhagen, Denmark on November 16, 2026. Newest first.

Approved from age 12.

Open the latest on the 3D globe →

Day by day

  1. Wegovy lowers BMI in children in trial
  2. Novo says Wegovy lowers BMI in children in trial

Every installment

Tuesday, November 17, 2026 · Day 2 · Health · Copenhagen, Denmark

Novo says Wegovy lowers BMI in children in trial

Novo Nordisk said Wegovy lowered BMI and obesity rates in children in a trial.

Why it matters: Possible first drug for under-12s.

Sources: CNBC · See it on the globe

Monday, November 16, 2026 · Day 1 · Health · Copenhagen, Denmark

Wegovy lowers BMI in children in trial

Novo Nordisk said Wegovy lowered BMI and obesity rates in children in a trial. No drug is approved for children under 12.

Why it matters: Younger children may gain a treatment option.

Sources: CNBC · See it on the globe

Where

More running stories →